Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T30372 | ||||
Target Name | Trypanosoma Cruzipain (Trypano CYSP) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | Drug Info | IC50 = 460 nM | [1] | ||
Drug Info | IC50 = 100 nM | [8] | |||
(3Z)-1H-indole-2,3-dione 3-thiosemicarbazone | Drug Info | IC50 = 8000 nM | [2] | ||
1-(1-(3-nitrophenyl)propylidene)thiosemicarbazide | Drug Info | IC50 = 860 nM | [3] | ||
1-(3,4-dihydronaphthalen-1-yl)ethanone | Drug Info | IC50 = 1360 nM | [3] | ||
1-(3-Methoxy-benzyl)-5-methyl-1H-indole-2,3-dione | Drug Info | IC50 = 2000 nM | [2] | ||
1-(bis(3-bromophenyl)methylene)thiosemicarbazide | Drug Info | IC50 = 24 nM | [3] | ||
2-(trifluoromethyl)benzaldehyde thiosemicarbazone | Drug Info | IC50 = 1300 nM | [1] | ||
2-methoxy-1-naphthaldehyde thiosemicarbazone | Drug Info | IC50 = 560 nM | [1] | ||
3'-bromopropiophenonethiosemicarbazone | Drug Info | IC50 = 40 nM | [8] | ||
3,5-dichlorobenzaldehyde thiosemicarbazone | Drug Info | IC50 = 560 nM | [1] | ||
3-(trifluoromethyl)benzaldehyde thiosemicarbazone | Drug Info | IC50 = 480 nM | [1] | ||
3-amino-5-(furan-2-yl)biphenyl-2,4-dicarbonitrile | Drug Info | IC50 = 12000 nM | [5] | ||
3-chloro-N-(4-(phenyldiazenyl)phenyl)benzamide | Drug Info | IC50 = 12000 nM | [5] | ||
5-(3,4-dichlorophenyl)-1H-pyrazol-3-ol | Drug Info | IC50 = 12000 nM | [5] | ||
5-(4-bromophenyl)-2-furaldehyde thiosemicarbazone | Drug Info | IC50 = 280 nM | [1] | ||
5-Chloro-1-(4-chloro-benzyl)-1H-indole-2,3-dione | Drug Info | IC50 = 6000 nM | [2] | ||
GNF-PF-4478 | Drug Info | Ki = 2000 nM | [7] | ||
K-777 | Drug Info | IC50 = 4 nM | [4] | ||
L-755507 | Drug Info | IC50 = 12000 nM | [5] | ||
MANIDIPINE | Drug Info | IC50 = 6000 nM | [6] | ||
N1,N4-bis(5-chloro-2-methylphenyl)succinamide | Drug Info | IC50 = 12000 nM | [5] | ||
TRICLABENDAZOLE | Drug Info | IC50 = 15000 nM | [6] | ||
VITAMIN K2 | Drug Info | IC50 = 18000 nM | [6] | ||
References | |||||
REF 1 | Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruz... J Med Chem. 2002 Jun 20;45(13):2695-707. | ||||
REF 2 | Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg Med Chem Lett. 2003 Oct 20;13(20):3527-30. | ||||
REF 3 | Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4405-9. | ||||
REF 4 | Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6218-21. | ||||
REF 5 | Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. J Med Chem. 2010 Jan 14;53(1):37-51. | ||||
REF 6 | Colloid formation by drugs in simulated intestinal fluid. J Med Chem. 2010 May 27;53(10):4259-65. | ||||
REF 7 | Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem. 2010 Jul 8;53(13):4891-905. | ||||
REF 8 | Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents. Bioorg Med Chem. 2010 Nov 15;18(22):7826-35. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.